|
[1]
|
Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., et al. (2018) Global Surveillance of Trends in Cancer Survival 2000-14 (CONCORD-3): Analysis of Individual Records for 37 513 025 Patients Diagnosed with One of 18 Cancers from 322 Population-Based Registries in 71 Countries. The Lancet, 391, 1023-1075. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Janmunee, N., Peerawong, T., Rordlamool, P., Bridthikitti, J., Tangthongkum, M., Kongkamol, C., et al. (2021) Tumor Volume as a Prognostic Factor on the Median Survival in Locally Advanced Oral Cancer Treated with Definitive Chemoradiotherapy. Indian Journal of Cancer, 60, 72-79. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Jardali, G., Lawrance, L., Dawi, L., et al. (2025) Baseline CT-Derived Tumor Burden and Liquid Biopsy as Biomarkers to Predict Survival in Patients with Metastatic Solid Cancer. Diagnostic and Interventional Imaging, 106, 430-437.
|
|
[4]
|
Nicolò, E., Tarantino, P., D’Ecclesiis, O., Antonarelli, G., Boscolo Bielo, L., Marra, A., et al. (2023) Baseline Tumor Size as Prognostic Index in Patients with Advanced Solid Tumors Receiving Experimental Targeted Agents. The Oncologist, 29, 75-83. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Sasaki, K., Morioka, D., Conci, S., Margonis, G.A., Sawada, Y., Ruzzenente, A., et al. (2018) The Tumor Burden Score: A New “Metro-Ticket” Prognostic Tool for Colorectal Liver Metastases Based on Tumor Size and Number of Tumors. Annals of Surgery, 267, 132-141. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Ho, S., Liu, P., Hsu, C., Huang, Y., Liao, J., Su, C., et al. (2022) A New Tumor Burden Score and Albumin-Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma. Cancers, 14, Article 649. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Iacovelli, R., Lanoy, E., Albiges, L. and Escudier, B. (2012) Tumour Burden Is an Independent Prognostic Factor in Metastatic Renal Cell Carcinoma. BJU International, 110, 1747-1753. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Gerber, D.E., Dahlberg, S.E., Sandler, A.B., Ahn, D.H., Schiller, J.H., Brahmer, J.R., et al. (2013) Baseline Tumour Measurements Predict Survival in Advanced Non-Small Cell Lung Cancer. British Journal of Cancer, 109, 1476-1481. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Wei, X., Xu, J., Wang, D., Chen, D., Ren, C., Li, J., et al. (2021) Baseline Lesion Number as an Efficacy Predictive and Independent Prognostic Factor and Its Joint Utility with TMB for PD-1 Inhibitor Treatment in Advanced Gastric Cancer. Therapeutic Advances in Medical Oncology, 13, 1-14.
|
|
[10]
|
Li, J., Zhu, H., Sun, L., Xu, W. and Wang, X. (2019) Prognostic Value of Site-Specific Metastases in Lung Cancer: A Population Based Study. Journal of Cancer, 10, 3079-3086. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Riihimäki, M., Hemminki, A., Fallah, M., Thomsen, H., Sundquist, K., Sundquist, J., et al. (2014) Metastatic Sites and Survival in Lung Cancer. Lung Cancer, 86, 78-84. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Ashour Badawy, A., Khedr, G., Omar, A., et al. (2018) Site of Metastases as Prognostic Factors in Unselected Population of Stage IV Non-Small Cell Lung Cancer. Asian Pacific Journal of Cancer Prevention, 19, 1907-1910.
|
|
[13]
|
Lenci, E., Marcantognini, G., Cognigni, V., Lupi, A., Rinaldi, S., Cantini, L., et al. (2021) Tumor Burden as Possible Biomarker of Outcome in Advanced NSCLC Patients Treated with Immunotherapy: A Single Center, Retrospective, Real-World Analysis. Exploration of Targeted Anti-Tumor Therapy, 2, 227-239. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Miyawaki, T., Kenmotsu, H., Mori, K., Miyawaki, E., Mamesaya, N., Kawamura, T., et al. (2020) Association between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer. Clinical Lung Cancer, 21, e405-e414. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Higuera Gomez, O., Moreno Paul, A., Ortega Granados, A.L., Ros Martinez, S., Perez Parente, D., Ruiz-Gracia, P., et al. (2021) “High Tumor Burden” in Metastatic Non-Small Cell Lung Cancer: Defining the Concept. Cancer Management and Research, 13, 4665-4670. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Yu, X.Q., Yap, M.L., Cheng, E.S., Ngo, P.J., Vaneckova, P., Karikios, D., et al. (2022) Evaluating Prognostic Factors for Sex Differences in Lung Cancer Survival: Findings from a Large Australian Cohort. Journal of Thoracic Oncology, 17, 688-699. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Metzenmacher, M., Griesinger, F., Hummel, H., Elender, C., Schäfer, H., de Wit, M., et al. (2023) Prognostic Factors in Nonsmall Cell Lung Cancer: Insights from the German CRISP Registry. European Respiratory Journal, 61, Article 2201336. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Polański, J., Chabowski, M., Świątoniowska-Lonc, N., Dudek, K., Jankowska-Polańska, B., Zabierowski, J., et al. (2021) Relationship between Nutritional Status and Clinical Outcome in Patients Treated for Lung Cancer. Nutrients, 13, Article 3332. [Google Scholar] [CrossRef] [PubMed]
|